Kang Y Michele 4
4 · REXAHN PHARMACEUTICALS, INC. · Filed Aug 27, 2008
Insider Transaction Report
Form 4
REXAHN PHARMACEUTICALS, INC.RXHN.OB
Kang Y Michele
Director
Transactions
- Award
Stock Options (right to buy)
[F1]2008-06-30+20,000→ 20,000 totalExercise: $3.24Exp: 2018-06-30→ Common Stock (20,000 underlying) - Award
Stock Options (right to buy)
[F2]2008-08-12+150,000→ 150,000 totalExercise: $1.47Exp: 2018-08-12→ Common Stock (150,000 underlying)
Holdings
- 20,000
Stock Options (right to buy)
Exercise: $1.20From: 2007-05-01Exp: 2016-05-01→ Common Stock (20,000 underlying) - 20,000
Stock Options (right to buy)
Exercise: $1.40From: 2007-06-11Exp: 2017-06-11→ Common Stock (20,000 underlying)
Footnotes (2)
- [F1]These options vest and become exercisable in full on June 30, 2009.
- [F2]30% of the options vest and become exercisable on August 12, 2009; another 30% of the options vest and become exercisable on August 12, 2010; and the remaining 40% of the options vest and became exercisable on August 12, 2011.
Signature
/s/ Tae Heum Jeong, as attorney-in-fact for Y. Michele Kang|2008-08-27